Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Indian Pediatr ; 2014 Oct; 51(10): 812-817
Artículo en Inglés | IMSEAR | ID: sea-170853
3.
Indian Pediatr ; 2006 Jan; 43(1): 44-8
Artículo en Inglés | IMSEAR | ID: sea-8404

RESUMEN

A retrospective analysis was done on 47 pediatric renal transplants performed over last 16 years at Bangalore, Karnataka. The median age and weight of the recipients at transplantation were 120 months and 21 kg respectively; male to female ratio was 30 to 17. Twenty two children had underlying glomerular disease and 23 had tubulointerstitial disease. Preemptive transplantation was done in 33.3% of patients, 57.2% received hemodialysis and 9.5% received peritoneal dialysis prior to transplantation. The mean duration of dialysis was 2.6 months.The most common source of donor organ was the mother. Immunosuppression medications included cyclosporine, azathioprine, and corticosteroids. Graft survival at 1 year, 5 years, and 10 years was 80%, 45.8% and 37.5% respectively. Renal transplantation is the most optimal way to manage children with ESRD with satisfactory long term results.


Asunto(s)
Cadáver , Preescolar , Femenino , Rechazo de Injerto , Supervivencia de Injerto , Humanos , India , Fallo Renal Crónico/diagnóstico , Trasplante de Riñón/inmunología , Donadores Vivos , Masculino , Complicaciones Posoperatorias/epidemiología , Pronóstico , Estudios Retrospectivos , Medición de Riesgo , Tasa de Supervivencia , Inmunología del Trasplante
4.
Indian Pediatr ; 2006 Jan; 43(1): 14-9
Artículo en Inglés | IMSEAR | ID: sea-14694

RESUMEN

OBJECTIVE: To evaluate the efficacy of cyclosporine (CyA) monotherapy in steroid resistant (SRNS) and steroid dependent (SDNS) nephrotic syndrome in children. DESIGN: A retrospective study. SETTING: Tertiary kidney care center for children at Bangalore. METHODS: Forty-one children with SDNS and SRNS with normal renal functions were treated with CyA at a dose of 6 mg/kg/day initially and maintained at 3 to 4 mg/kg/day if remission was sustained. The dosage was adjusted according to the CyA blood levels in non-responders. RESULTS: The median age of patients was 93 months (range 48-936) months. Thirteen children had minimal change disease (MCNS), 10 had mesangial proliferative glomerulonephritis (GN). Ten had membrano-proliferative (GN) (MPGN) and 8 had focal segmental glomerulosclerosis (FSGS). Median age at onset of disease and median time for CyA usage from disease onset was 22 months and 16 months respectively. Median duration of CyA therapy was 24 months (range 6-72) months. The data was analyzed to determine significance of variables on the outcome. Median follow up was 71 months (range 20-205) months. Eleven children were CyA resistant. Of the remaining 30 who were CyA responders, 22 (73.33%) were CyA dependent. Seven children developed chronic renal failure (CRF). CONCLUSIONS: The predictors for CyA non-responsiveness were steroid resistance, non MCNS on biopsy and longer duration between onset of nephrotic syndrome and CyA usage, irrespective of the age of onset of the disease. There was a higher incidence of CyA dependence among young responders. Patients with CyA resistance are at high risk for significant infections and CRF.


Asunto(s)
Estudios de Casos y Controles , Niño , Preescolar , Ciclosporina/uso terapéutico , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Resistencia a Medicamentos , Femenino , Estudios de Seguimiento , Humanos , Pruebas de Función Renal , Modelos Logísticos , Masculino , Síndrome Nefrótico/diagnóstico , Probabilidad , Estudios Prospectivos , Valores de Referencia , Medición de Riesgo , Índice de Severidad de la Enfermedad , Esteroides/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA